γδ T-cell neoplasms: A clinicopathological study of 11 cases

Annals of Oncology

Volumn 13, Issue 11, 2002, Pages 1792-1798

  Saito, T ^a   Matsuno, Y ^a   Tanosaki, R ^a   Watanabe, T ^a   Kobayashi, Y ^a   Tobinai, K ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

T cell neoplasm; Nodal T cell lymphoma; T cell receptor

Indexed keywords

ASPARAGINASE; BLEOMYCIN; CD2 ANTIGEN; CD3 ANTIGEN; CD5 ANTIGEN; CD7 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; ENOCITABINE; ETOPOSIDE; METHOTREXATE; METHYLPREDNISOLONE; MITOXANTRONE; NIMUSTINE; PREDNISOLONE; PROCARBAZINE; T LYMPHOCYTE ANTIGEN; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; VINCRISTINE; VINDESINE;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CLINICAL ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LIVER TUMOR; LYMPH NODE; LYMPHATIC LEUKEMIA; MALE; PATHOLOGY; PERIPHERAL T CELL LYMPHOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; SKIN LYMPHOMA; T CELL LEUKEMIA; T CELL LYMPHOMA; TONSIL TUMOR; TUMOR CELL;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY, NEEDLE; BONE MARROW TRANSPLANTATION; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOMA, T-CELL, PERIPHERAL; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0036860306     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdf293     Document Type: Article

References (30)

1. Falini B, Flenghi L, Pileri S et al. Distribution of T cells bearing a different form of the T cell receptor γ/δ in normal and pathological human tissues. J Immunol 1989; 143: 2480-2488.
2. Groh V, Porcelli S, Fabbi M et al. Human lymphocytes bearing T cell receptor γ/δ are phenothypically diverse and evenly distributed thoughout the lymphoid system. J Exp Med 1989; 169: 1277-1294.
3. de Villartay JP, Pullman AB, Andrade R et al. γ/δ Lineage relationship within a consecutive series of human precursor T-cell neoplasms. Blood 1989; 74: 2508-2518.
4. Picker L, Brenner M, Michie S, Warnke RA. Expression of T cell receptor δ chains in benign and malignant T lineage lymphoproliferations. Am J Pathol 1988; 132: 401-405.
5. Fisch P, Malkovsky M, Kovats S et al. Recognition by human V9/V2 T cells of a GroEL homolog on Daudi Burkitt's lymphoma cells. Science 1990; 250: 1269-1273.
6. Bukowski JF, Morita CT, Tanaka Y et al. V2V2 TCR-dependent recognition of nonpeptide antigens and Daudi cells analyzed by TCR gene transfer. J Immunol 1995; 154: 998-1006.
7. Falini B, Flenghi L, Fagioli M et al. T-lymphoblastic lymphomas expressing the non-disulfide-linked form of the T-cell receptor γ/δ: characterization with monoclonal antibodies and genotypic analysis. Blood 1986; 74: 2501-2507.
8. - T-cell acute lymphoblastic leukemias: a report of five cases. Blood 1991; 77: 2023-2030.
9. Campana D, Couston-Smith E, Behm F, Goorha R. Normal and aberrant T-cell receptor protein expression in T-cell acute lymphoblastic leukemia. Recent Results Cancer Res 1993; 131: 19-30.
10. + T-lineage acute lymphoblastic leukemia. Br J Haematol 1998; 101: 753-755.
11. Farcet JP, Gualard P, Marolleau J-P et al. Hepatosplenic T-cell lymphoma: Sinusal/Sinusoidal localization of malignant cells expressing the T-cell receptor γδ. Blood 1990; 75: 2213-2219.
12. Arnulf B, Copie-Bergman C, Delfau-Larue MH et al. Nonhepatosplenic γδ T-cell lymphoma: A subset of cytotoxic lymphomas with mucosal or skin location. Blood 1998; 91: 1723-1731.
13. Yamaguchi M, Ohno T, Nakamine H et al. γδ T-cell lymphoma: A clinicopathologic study of six cases including extrahepatosplenic type. Int J Hematol 1999; 69: 186-195.
14. Picker LJ, Brenner MB, Michie S, Warnke RA. Expression of T cell rereceptor δ chains in benign and malignant T lineage lymphoproliferations. Am J Pathol 1988; 132: 401-405.
15. Gaulard P, Bourquelot P, Kanavaros P et al. Expression of the α/β and γ/δ T-cell receptors in 57 cases of peripheral T-cell lymphomas. Am J Pathol 1990; 137: 617-628.
16. Yamaguchi M, Ohno T, Kita K. γδ T-cell lymphoma of the thyroid gland. N Engl J Med 1997; 336: 1391-1392.
17. - γδ T cell lymphoma: a case report with multiparameter analyses. Hum Pathol 1996; 27: 1370-1377.
18. Kagami Y, Nakamura S, Suzuki R et al. A nodal γ/δ T-cell lymphoma with an association of Epstein-Barr virus. Am J Surg Pathol 1997; 21: 729-736.
19. Ohshima K, Suzumiya J, Sugihara M et al. Clinical, immunohistochemical and phenotypic features of aggressive nodal cytotoxic lymphomas, including α/β, γ/δ T-cell and natural killer cell types. Virchows Arch 1999; 435: 92-100.
20. Harris NL, Jaffe ES, Stein H et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-1392.
21. Saito T, Togitani K, Murakami J et al. Granular lymphocytic leukemia derived from γδ T-cell expressing cytotoxic molecules. Leuk Res 2001; 25: 259-261.
22. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993; 329: 987-994.
23. Velasquez WS, Mclaughlin P, Tucker S et al. ESHAP-an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study. J Clin Oncol 1994; 12: 1169-1176.
24. Wilson WH, Bryant G, Bates S et al. EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma. J Clin Oncol 1993; 11: 1573-1582.
25. Bank I, DePinho RA, Brenner MB et al. A functional T3 molecule associated with a novel heterodimer on the surface of immature human thymocytes. Nature 1986; 322: 179-181.
26. Charton-Bain MC, Brousset P, Bouabdallah R et al. Variation in the histological pattern of nodal involvement by γ/δ T-cell lymphoma. Histopathology 2000; 36: 233-239.
27. Wong KF, Chan JKC, Matutes E et al. Hepatosplenic γδ T-cell lymphoma, a distinct aggressive lymphoma type. Am J Surg Pathol 1995; 19: 718-726.
28. Kagami Y, Suzuki R, Taji H et al. Nodal cytotoxic lymphoma spectrum: a clinicopathologic study of 66 patients. Am J Surg Pathol 1999; 23: 1184-1200.
29. Kanavaros P, Lescs MC, Briere J et al. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood 1993; 81: 2688-2695.
30. Harabuchi Y, Imai S, Wakashima J et al. Nasal T-cell lymphoma causally associated with Epstein-Barr virus. Cancer 1996; 77: 2137-2149.